Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1999

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

EmphysemaLung DiseasesLung Diseases, ObstructiveChronic Obstructive Pulmonary Disease

Interventions

DRUG

all trans retinoic acid

DRUG

13 cis retinoic acid

DRUG

placebo

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000621 - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) | Biotech Hunter | Biotech Hunter